Contact Erwinaze

For all inquiries regarding Erwinaze in the US, please contact Customer Service by phone at:
(800) 833-3533, via email at service-us@eusapharma.com, or by mail at:

EUSA Pharma (USA), Inc.
One Summit Square
1717 Langhorne-Newtown Road, Suite 201
Langhorne, PA 19047

Tel: +1 (215) 867-4900
Fax: +1 (215) 579-0384

Please follow this link to CME Grant Requests page.

CONTRAINDICATIONS: Hx of serious hypersensitivity to Erwinaze, including anaphylaxis; Hx of serious pancreatitis, thrombosis or hemorrhage with prior L-asparaginase therapy.

WARNINGS AND PRECAUTIONS: Discontinue if serious hypersensitivity, including anaphylaxis, OR severe or hemorrhagic pancreatitis occur. Monitor glucose (intolerance may not be reversible); With thrombosis and hemorrhage: discontinue until resolved. Use in pregnant women only if clearly needed. Do not use in lactating women.

COMMON (≥ 1%) ADVERSE REACTIONS: Serious hypersensitivity, including anaphylaxis, pancreatitis, abnormal transaminases, coagulation abnormalities, nausea, vomiting, and hyperglycemia.

Please see full Prescribing Information.

This site is only intended for residents of the United States.